Which of the following may be seen during clinical examination in a patient of Diabetes mellitus? 1. Necrobiosis lipoidica 2. Charcot neuroarthropathy 3. Exudative maculopathy 4. Acanthosis nigricans Select the correct answer using the code given below:
1, 2, 3 and 4
All four are recognized diabetic complications/associations: necrobiosis lipoidica (skin), Charcot neuroarthropathy (diabetic neuropathic joint disease), exudative (diabetic) maculopathy (retinopathy), and acanthosis nigricans (marker of insulin resistance). Hence all four statements are correct.
Consider the following statements regarding glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP):
1. GLP-1 is an incretin hormone.
2. GIP is an incretin hormone.
3. GLP-1 is released from gastrointestinal 'L-cells'.
4. GIP is released from gastrointestinal 'M-cells'.
Which of the statements given above are correct?
Which of the following are long-acting insulin analogues?
1. Lispro
2. Glargine
3. Detemir
4. Degludec
Select the correct answer using the code given below:
Which one of the following drugs is not a secondary cause of weight gain?
Which one of the following levels of hypoglycaemia corresponds to a blood glucose level of 50 mg/dL leading to cognitive impairment and need for corrective treatment?